2012
DOI: 10.1186/1742-2094-9-199
|View full text |Cite
|
Sign up to set email alerts
|

Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

Abstract: BackgroundAlzheimer’s disease (AD) involves increased accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles as well as neuronal loss in various regions of the neocortex. Neuroinflammation is also present, but its role in AD is not fully understood. We previously showed increased levels of pro-inflammatory cytokine interleukin-18 (IL-18) in different regions of AD brains, where it co-localized with Aβ-plaques, as well as the ability of IL-18 to increase expression of glycogen synthase kinase-3β (GS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
120
0
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 185 publications
(139 citation statements)
references
References 108 publications
(136 reference statements)
10
120
0
2
Order By: Relevance
“…IRAK1 inhibitors could therefore have therapeutic potential for the treatment of autoimmune diseases that are linked to the overproduction of type 1 IFNs by pDCs (Barrat et al, 2005). They might also reduce IL-18 secretion by inflammasomes, and so reduce IL-18-stimulated production of type II interferon (IFNc) by T cells, which is associated with severe inflammatory reactions, and autoimmune and other diseases Sutinen et al, 2012). In mouse and human macrophages, IRAK2 is required for the TLR-dependent production of proinflammatory cytokines (Flannery et al, 2011;Pauls et al, 2013).…”
Section: Targeting Kinases To Develop Improved Anti-inflammatory Drugsmentioning
confidence: 99%
“…IRAK1 inhibitors could therefore have therapeutic potential for the treatment of autoimmune diseases that are linked to the overproduction of type 1 IFNs by pDCs (Barrat et al, 2005). They might also reduce IL-18 secretion by inflammasomes, and so reduce IL-18-stimulated production of type II interferon (IFNc) by T cells, which is associated with severe inflammatory reactions, and autoimmune and other diseases Sutinen et al, 2012). In mouse and human macrophages, IRAK2 is required for the TLR-dependent production of proinflammatory cytokines (Flannery et al, 2011;Pauls et al, 2013).…”
Section: Targeting Kinases To Develop Improved Anti-inflammatory Drugsmentioning
confidence: 99%
“…These have been supported 23 by reports demonstrating that Aβ peptides could activate NF-κB in neurons [10]. 24 NFκB pathway therefore provides an important target in the understanding of 25 mechanisms involved in modulating inflammation in the neurons. 26 Accumulation of extracellular Aβ plaques in neurons is one of the important 27 pathological hallmarks in AD.…”
mentioning
confidence: 78%
“…In vivo показано, что вос-паление сопровождается образованием и накопле-нием β-амилоида [21]. β-Амилоид активирует ми-кроглию и астроциты, которые в свою очередь запу-скают процесс высвобождения провоспалительных цитокинов, ингибирующих рецепторы инсулина за счет увеличения форфорилирования серина IRS-1 (insulin substrate-1) и протеинкиназы В (Akt-киназы), что способствует развитию нейродегенера-ции [28].…”
Section: Discussionunclassified
“…В ольфакторной луковице наблюдалась тенденция к повышению экспрессии IL-18 у крыс с моделированной нейродегенерацией. Это может свидетельствовать об активации воспалительного процесса за счет сборки внутриклеточных инфлам-масом [21].…”
Section: результатыunclassified